NovaBay Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2008 Financi... ($7.4 million for the full year 2007. Th...)

NovaBay Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2008 Financial Results

Date:4/1/2009

$7.4 million for the full year 2007. The increase was primarily attributable to an increase in development/clinical expenses and higher employee costs due to an increase in headcount.

General and administrative expenses totaled $5.6 million for the year ended December 31, 2008, compared with $4.4 million for the year-ago period. This increase was due in part to an increase in employee costs and related increases in other employee benefits and recruiting expenses

About NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals is a mid-stage biopharmaceutical company focused on developing its proprietary and patented Aganocide compounds, first-in-class, novel, synthetic anti-infective product candidates that are bioequivalent to the active antimicrobial molecules generated within white blood cells to treat and prevent a wide range of infections without causing resistance. NovaBay has internal development programs aimed at addressing hospital and respiratory infections. The company has a licensing and research collaboration agreement with Alcon, Inc. for use of its Aganocides in the eye, ear and sinus, and in contact lens solutions. NovaBay has entered into an agreement with Galderma S.A. to develop and commercialize Aganocides in acne, impetigo and other dermatological indications. NovaBay(R) and Aganocide(R) are trademarks of NovaBay Pharmaceuticals, Inc. For more information on NovaBay, visit www.novabaypharma.com.

Forward-Looking Statements

This release contains forward-looking statements, which are based upon management's current expectations, assumptions, estimates, projections and beliefs. Statements regarding NovaBay's expectations of its 2009 cash burn, anticipation of proof-of-concept data later in 2009 on its earlier-stage internal pipeline programs, that it will receive from Galderma up to $50 million
'/>"/>

SOURCE NovaBay Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Post Your Comments:

(Date:12/15/2009)... Reportlinker.com announces that a new market research ... The Future of Orphan Diseases ... Analysis and Reimbursement ,, ... Summary ,, The author has released ... Diseases Therapeutics - Market Forecasts to 2015, ...

(Date:12/15/2009)... Minn., Dec. 15 The Mosaic Company (NYSE: ... fiscal year 2010 earnings results and financial tables on ... on the New York Stock Exchange. Results will ... ,, The Company will host a conference call with ... the results. The call will begin at 11:00 ...

(Date:12/15/2009)... and LONDON, Dec. 15 ... Thomson Pharma ® has become the first drug ... protocol and outcome information. This highly anticipated new ... customers this month. ,, Thomson ... intelligence from registries, publications, press releases, conferences, and ...

(Date:12/14/2009)... Dec. 14 Vermillion, Inc. (Pink ... announced William C. Wallen, Ph.D. Chief Scientific ... for IDEXX Laboratories, will be joining its ... bankruptcy plan. ,, "Bill brings more ... in diagnostics and biotechnology," said Gail Page, ...

[0] Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement [0] Mosaic Announces Second Quarter Fiscal Year 2010 Earnings Release and Conference Call [0] Thomson Reuters is First to Offer Fully Integrated Pipeline and Clinical Trials [0] Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors

... system that incorporates phased Array IVUS, Rotational, IVUS and ... ... and Administrators Choice, SAN DIEGO, Feb. 7 ... ultrasound (IVUS),and functional measurement (FM) technology, announced today FDA 510(k),clearance ...

... Preeminent Team of Medical Advisers Helps Guide New Service ... the planned launch of a new Alzheimer,s risk assessment ... a service agreement,with one of the leading laboratory testing ... Genetics is to provide people with accurate,information about their ...

... Calif., Feb. 7 Documents,detailing the California stem ... relations firm reveal an agency,leadership worried about the ... secret by channeling it through an outside law ... said today., The stem cell institute, a ...

Other Biology Technology:Volcano Announces FDA 510(k) Clearance of Revolution Rotational Catheter and FFR for the s5i Integrated IVUS Console 2 Volcano Announces FDA 510(k) Clearance of Revolution Rotational Catheter and FFR for the s5i Integrated IVUS Console 3 Volcano Announces FDA 510(k) Clearance of Revolution Rotational Catheter and FFR for the s5i Integrated IVUS Console 4 Volcano Announces FDA 510(k) Clearance of Revolution Rotational Catheter and FFR for the s5i Integrated IVUS Console 5 Smart Genetics Announces Plans to Launch a New Alzheimer's Risk Assessment Service 2 Smart Genetics Announces Plans to Launch a New Alzheimer's Risk Assessment Service 3 'Crisis Management' PR Firm's Advice to Stem Cell Agency Laundered Through Law Firm to Avoid Scrutiny 2 'Crisis Management' PR Firm's Advice to Stem Cell Agency Laundered Through Law Firm to Avoid Scrutiny 3

Volcano Announces FDA 510(k) Clearance of Revolution Rotational Catheter and FFR for the s5i Integrated IVUS Console Smart Genetics Announces Plans to Launch a New Alzheimer's Risk Assessment Service 'Crisis Management' PR Firm's Advice to Stem Cell Agency Laundered Through Law Firm to Avoid Scrutiny

(Date:12/16/2009)... -- BIO-key International, Inc. (OTC Bulletin Board: ... and finger-based biometric identification solutions, announced that ... Special Shareholder Meeting held today approved the ... to Interact911 Mobile Systems Inc. Of the ... and 1.2% were opposed. ,, (Logo: ...

(Date:12/16/2009)... 9 BIO-key International, Inc. (OTC ... biometric identification solutions, today announced that SC ... security publications, named BIO-key International the 2009 ... Control sub-category Biometrics. ,, (Logo: ... technology editor, SC Magazine, "Biometric providers have ...

(Date:12/15/2009)... -- The 2009 Frost & Sullivan European ... to Sagem Securite (Safran Group) for its ... recognises the company,s expertise in advanced biometric ... novel, value-added products to end users. ... "Sagem Securite has been involved in delivering ...

Breaking Biology News(10 mins):BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 2 BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 3 BIO-key(R) Selected as 2009 Industry Innovator in Biometrics by SC Magazine 2 BIO-key(R) Selected as 2009 Industry Innovator in Biometrics by SC Magazine 3 Frost & Sullivan Recognises Sagem Securite for its Innovative Automated Border Control Systems 2 Frost & Sullivan Recognises Sagem Securite for its Innovative Automated Border Control Systems 3 Frost & Sullivan Recognises Sagem Securite for its Innovative Automated Border Control Systems 4 Dartmouth gets 243 million from the National Science Foundation for IT research in health care 53743 1 Dartmouth gets 243 million from the National Science Foundation for IT research in health care 53743 2 Dartmouth gets 243 million from the National Science Foundation for IT research in health care 53743 3 Beautiful plumage 3A Feather color and sex start the species revolution 9485 1 Growing evidence of marijuana smokes potential dangers 9480 1

[0] BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division [0] BIO-key(R) Selected as 2009 Industry Innovator in Biometrics by SC Magazine [0] Frost & Sullivan Recognises Sagem Securite for its Innovative Automated Border Control Systems

... the mechanism by which adult stem cells are integrated ... however, about the mechanism on which repair processes are ... and Lung Research in Bad Nauheim, Germany, in co-operation ... now shown that skeletal muscle tissue can fuse with ...

... over 200 years? I'd like to see how they calculated that, ... don't panic just yet! Still, if it's a real trend, it ... of acid to change its pH, I guess! , A ... alarm about the world's oceans. "If CO2 from human activities continues ...

... in different subtypes of avian flu viruses shows that ... worldwide, but is especially prevalent in China, according to ... is spreading more rapidly among avian influenza viruses of ... according to the study done by investigators at St. ...

Other Biology News:Tissue regeneration operates differently than expected 2 Tissue regeneration operates differently than expected 3 Oceans turning to acid from rise in CO2 2 Drug resistant avian influenza viruses more common in Southeast Asia than North America 2 Drug resistant avian influenza viruses more common in Southeast Asia than North America 3 Drug resistant avian influenza viruses more common in Southeast Asia than North America 4

Tissue regeneration operates differently than expected Oceans turning to acid from rise in CO2 Drug resistant avian influenza viruses more common in Southeast Asia than North America

Jak3 Antibody Ship: Hot Store: -20 C...

WASF2 Immunogen: WASF2 (NP_008921, 73 a.a. ~ 173 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...

Applications: Western blotting Stability: Room temperature, indefinitely ...

...

Biology Products:

Anti-Jak3 Antibody, Unconjugated from Cell Signaling Technology Mouse Anti-Human WASF2 Polyclonal Antibody, Unconjugated from ABR-Affinity BioReagents Film Exposure Folders from Upstate TenderTouch™ from RNAture, Inc.

NovaBay Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2008 Financi...($7.4 million for the full year 2007. Th...)